Erin D. Michos, M.D.
@ErinMichos
Johns Hopkins Medicine. Associate Professor, Cardiology. Co-Editor in Chief @AJPCardio. #WomenHeartHealth #CardioObstetrics #cvPrev #echofirst She/her #BeKind
ID:2934375069
http://www.hopkinsmedicine.org/profiles/results/directory/profile/0015713/erin-michos 20-12-2014 23:42:12
32,6K Tweets
26,5K Followers
9,6K Following
#Black #women are disproportionately affected by #CV D with an excess burden of #CV #morbidity and #mortality 👉 bit.ly/3TyMRgN #disparity #CardioEd #MedEd #publichealth JACC Journals Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 Julia Grapsa Minnow Walsh, MD, MACC MIЯVΛƬ #IC Mamas A. Mamas John P Erwin III MD FACC
Thank you Erin D. Michos, M.D. for grooming me for this success. I would not have imagined myself in this position a year ago if it was not for your mentorship. It’s a privilege to have made these contributions to CardioObs under your wings!
I am extremely grateful for the mentorship of Erin D. Michos, M.D. which made this work possible. Thanks to all co-authors for their invaluable input. #Cardiology #CardioTwitter #CardioObs
I had such a great time making this episode. Huge thanks to Erin D. Michos, M.D. for reaching our 'guest second-timers' club. If you get your card stamped on the next one, you'll get a free caffeinated beverage. Special thanks to Ohio State Internal Medicine Residency Dr. Jimmy Antaki for the show notes!
Stay up to date on the latest clinical data on obesity and the impact of weight loss on CV risk in women with this newly posted #CME activity: ow.ly/HNBF50LeJlN @drmarthagulati Erin D. Michos, M.D. Pam R. Taub, MD
#Postmenopausal #women with h/o #premature #menopause or early menopausal age may have ⬆️ risk of #HF by3️⃣3️⃣% and #AFib by 9️⃣% 👉 bit.ly/3gv2JT6 #CardioEd #MedEd #CVD Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 Mamas A. Mamas Julia Grapsa Erin D. Michos, M.D. Gina Lundberg MD FACC FAHA John P Erwin III MD FACC MIЯVΛƬ #IC
In our new paper, we show that elevated Lp(a) is an important❤️risk factor in primary #prevention , even when LDL-C is optimal #MedTwitter Aziz Hammoud, MD MS Nick Ashburn Erin D. Michos, M.D. Parag Chevli MD MS Michael D. Shapiro Wake Forest Baptist Health Cardiology Atherosclerosis
doi.org/10.1016/j.athe…
Excellent summary of session covering how to assess risk in primary prevention Michael J. Blaha , residual risk post statin in secondary prevention Erin D. Michos, M.D. and where and when to use new therapies Pam R. Taub, MD
Fabulous talk by Pam R. Taub, MD about the new landscape & new tools for LDL-C lowering to help reduce vascular events in our patients at very high risk. #CMHC 17thAnnual #CMHC Cardiometabolic Health Congress
Outstanding panel discussion at the #cmhc17thannual talking about challenging cases in preventing cardiology. Great to be here in person Cardiometabolic Health Congress Michael J. Blaha Erin D. Michos, M.D. Christie Ballantyne Pam R. Taub, MD Drs Robert Eckel and Patrick Moriarty.
Love talking about prevention & lipids with these Cardiometabolic all-stars. Watch our recap of this morning's #CMHC 17thAnnual #CMHC conference with Michael J. Blaha Christie Ballantyne Pam R. Taub, MD . Live from Boston. Cardiometabolic Health Congress
Here is Erin D. Michos, M.D. reviewing some phase 2 IL-6i data at Cardiometabolic Health Congress. All eyes on ZEUS 👀 clinicaltrials.gov/ct2/show/NCT05… Novo Nordisk
Erin D. Michos, M.D. Pam R. Taub, MD love the slide depicting the myriad of risks driving ASCVD! Much work to be done #cmhc17thannual